Reuters logo
BRIEF-Tasly Pharmaceutical Group says JV receives clinical trial approval
July 17, 2017 / 6:20 AM / 4 months ago

BRIEF-Tasly Pharmaceutical Group says JV receives clinical trial approval

July 15 (Reuters) - Tasly Pharmaceutical Group Co Ltd

* Says 50 percent owned JV received clinical trial approval from China Food and Drug Administration regarding injection for hepatitis B treatment

Source text in Chinese:goo.gl/pz71Nm

Further company coverage: (Beijing Headline News)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below